Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2005
09/14/2005EP1572203A1 Substituted 4-alkoxyoxazol derivatives as ppar agonists
09/14/2005EP1572127A2 Enzyme treatment of foodstuffs for celiac sprue
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1461318B1 Tetrahydroquinoline analogues as muscarinic agonists
09/14/2005EP1385834B1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
09/14/2005CN1668605A Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
09/14/2005CN1668604A Novel anthracene derivatives and the use thereof as a medicament
09/14/2005CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668308A Oxazolidinone derivatives as antimicrobials
09/14/2005CN1668300A Spirocyclic piperidines as MCH1 antagonists and uses thereof
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/13/2005US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis
09/13/2005CA2371587C Piperidine derivatives useful as ccr5 antagonists
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/09/2005WO2005083771A1 Assembly of a semiconductor die attached to substrate with oxazoline derivative bearing an electron donor or acceptor functionality
09/09/2005WO2005082900A2 Oxazolidinone amidoximes as antibacterial agents
09/09/2005WO2005082899A1 Oxazolidinone derivatives as antimicrobials
09/09/2005WO2005082898A1 Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
09/09/2005WO2005082897A1 Oxazolidinone antibacterial agents
09/09/2005WO2005082896A1 Nucleoside analogues with antiviral activity
09/09/2005WO2005082895A1 Novel carboxamides for use as xa inhibitors
09/09/2005WO2005082892A2 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082885A1 Imidazole based kinase inhibitors
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082864A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
09/09/2005WO2005082863A2 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
09/09/2005WO2005082859A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
09/09/2005WO2005082858A2 Isoquinoline derivatives
09/09/2005WO2005082856A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082848A2 Method for preparing pyrrolidine oximes
09/09/2005WO2005061468A8 Halogenated biaryl heterocyclic compounds and methods of making and using the same
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005046603A3 Pyridine compounds
09/09/2005WO2005044192A3 Triazole compounds and uses related thereto
09/09/2005WO2005032493A3 Amide compounds as ion channel ligands and uses thereof
09/09/2005WO2005018568A3 Inhibitors of cathepsin s
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2555720A1 Isoquinoline derivatives
09/09/2005CA2554767A1 Method for preparing pyrrolidine oximes
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050197375 Use of benzimidazole analogs in the treatment of cell proliferation
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/08/2005US20050197370 Novel pentafluorosulfanyl compounds
09/08/2005US20050197368 Novel compounds as inhibitors of cell proliferation and viral infections
09/08/2005US20050197364 Amide compounds as ion channel ligands and uses thereof
09/08/2005US20050197361 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs
09/08/2005US20050197338 Substituted pyrazole urea compounds for the treatment of inflammation
09/08/2005US20050197337 Aminomethylpyrimidines as allosteric enhancers of the GABAB receptors
09/08/2005US20050197336 2-[4-(naphtha-2-yl-4-sulfonyl)-piperazin-1-yl]-thiazole-5-carboxylic acid hydroxyamide; antiproliferative agent; synergestic mixture with other anticarcinogenic agents; cell cycle arrest, cellular differentiation, apoptosis and reversal of the trans-formed phenotype
09/08/2005US20050197334 triazoles and optionally carrier mixtures used for prohylaxis of infections, as antiproliferative agents, fungicides, bactericides, parasiticides, viricides, antiinflammatory agents and/or prokinetic agents (gastrointestinal modulatory)
09/08/2005US20050197327 Compounds, compositions, and methods
09/07/2005EP1571154A1 Beta-aminoacid-derivatives as factor Xa inhibitors
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1571144A1 Hydroxyalkylated cyclic diamine compound
09/07/2005EP1570846A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use
09/07/2005EP1569934A2 Cyclopropyl compounds as ccr5 antagonists
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569931A1 Heterocyclic compounds as ccr5 antagonists
09/07/2005EP1569930A1 Indol derivatives and their use as 5-ht ligands
09/07/2005EP1569927A2 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
09/07/2005EP1569917A1 Pyrazine-based tubulin inhibitors
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569653A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005EP1347957B1 Delta 1-pyrrolines used as pesticides
09/07/2005EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists
09/07/2005EP1282621B1 Vitronectin receptor antagonists
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1189893B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
09/07/2005EP1188747B1 Phenoxypropylamine compounds
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005EP0888310B1 Cinnoline derivatives and use as medicine
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders
09/07/2005CN1665501A Novel compounds as opioid receptor modulators
09/07/2005CN1665500A Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
09/07/2005CN1217942C Pyrrolidine derivatives having phospholipase A inhibitory activity
09/07/2005CN1217940C Naphthol derivatives
09/07/2005CN1217922C 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
09/06/2005US6939988 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
09/06/2005US6939885 Sulfur compounds such as 4-tert-Butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide, used as chemokine receptor antagonists, antiinflamatory agents or as immunology modulators
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939882 Fungicides
09/06/2005US6939880 Compounds with growth hormone releasing properties
1 ... 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 ... 647